AZACITIDIN STADA

Powder for suspension for injection, 25mg/ml
RxActive license

Active substance (INN)

azacitidine

Pharmaceutical form

Pharmaceutical formPowder for suspension for injection
Strength25mg/ml
PackagingUkupno 1 bočica staklena sa praškom za suspenziju za injekciju u kartonskoj kutiji
ManufacturerStada Arzneimittel AG, Germany
Therapeutic groupAntineoplastic and immunomodulating agents (L01BC07)
Marketing authorization holderHEMOFARM A.D. VRŠAC P.J. PODGORICA
Authorization dateNovember 25, 2022

Analogs in Montenegro

4

Other medicines with the same active substance

AZACITIDIN HFRx
Powder for suspension for injection, 25mg/mlStada Arzneimittel AG
AZACITIDIN HFRx
Powder for suspension for injection, 25mg/mlStada Arzneimittel AG
AZACITIDINE ACCORDRestricted
Powder for suspension for injection, 25mg/mlAccord Healthcare Polska Sp. z o.o. Magazyn Importera
VIDAZARx
Powder for suspension for injection, 100mgBaxter Oncology GmbH
Source: CInMED register